---
title: "ALK released its performance for the first half of the year, with a net profit attributable to the parent company of 65.9251 million yuan, a year-on-year decrease of 3.19%"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/254857295.md"
description: "ALK released its semi-annual report for 2025, with operating revenue of 724 million yuan, a year-on-year decrease of 14.52%; net profit attributable to the parent company was 65.9251 million yuan, a year-on-year decrease of 3.19%; net profit excluding non-recurring gains and losses was 43.6969 million yuan, a year-on-year decrease of 26.77%; basic earnings per share were 0.33 yuan"
datetime: "2025-08-27T16:02:02.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/254857295.md)
  - [en](https://longbridge.com/en/news/254857295.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/254857295.md)
generator: "portal-rs"
---

# ALK released its performance for the first half of the year, with a net profit attributable to the parent company of 65.9251 million yuan, a year-on-year decrease of 3.19%

According to the Zhitong Finance APP, ALK (002940.SZ) released its semi-annual report for 2025. During the reporting period, the company achieved operating revenue of 724 million yuan, a year-on-year decrease of 14.52%. The net profit attributable to shareholders of the listed company was 65.9251 million yuan, a year-on-year decrease of 3.19%. The net profit attributable to shareholders of the listed company after deducting non-recurring gains and losses was 43.6969 million yuan, a year-on-year decrease of 26.77%. The basic earnings per share were 0.33 yuan

### Related Stocks

- [002940.CN](https://longbridge.com/en/quote/002940.CN.md)

## Related News & Research

- [Promise Analyzes Telehealth Licensing Rules as Compact Hits Record 3,633 Licenses in a Month](https://longbridge.com/en/news/296635882.md)
- [US health agencies report 55 cases of E. coli and salmonella infections tied to alfalfa sprouts](https://longbridge.com/en/news/296645342.md)
- [Navigator invests about EUR 115 million in new tissue paper machine at Aveiro complex](https://longbridge.com/en/news/296775961.md)
- [REG - Aberdeen Asian Inc - Director/PDMR Shareholding](https://longbridge.com/en/news/296505605.md)
- [Orum Therapeutics Announces U.S. FDA Clearance of an IND Application for ORM-1153, a Novel CD123-GSPT1 Degrader-Antibody Conjugate](https://longbridge.com/en/news/296689195.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**